Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04516655` - A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients	Phase 2
Recruiting	`NCT05054426` - Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL	Phase 3
Recruiting	`NCT02623010` - Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma	Phase 2
Recruiting	`NCT04548648` - A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas	Phase 2
Active, not recruiting	`NCT00293475` - Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma	Phase 1/Phase 2
Completed	`NCT03342586` - Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity
Terminated	`NCT02420795` - Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma	Phase 1/Phase 2
Completed	`NCT01011920` - Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma	Phase 2
Completed	`NCT00967200` - Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	N/A
Recruiting	`NCT03684980` - LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma	Early Phase 1
Not yet recruiting	`NCT06213636` - Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).	Phase 1/Phase 2
Recruiting	`NCT04938297` - Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma	Phase 2
Completed	`NCT01458730` - Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma	Phase 2
Completed	`NCT00153530` - Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)	Phase 4
Recruiting	`NCT04186520` - CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies	Phase 1/Phase 2
Recruiting	`NCT05816746` - Decitabine and Anti-PD-1 in R/R DLBCL	Phase 2
Recruiting	`NCT06031194` - Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma
Active, not recruiting	`NCT03962127` - MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway
Recruiting	`NCT05114330` - Secondary Central Nervous System Lymphoma Registry - Charité
Completed	`NCT00103038` - Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases	N/A

NCT number	NCT03690895
Study type	Observational
Source	Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status	Completed
Phase
Start date	March 15, 2015
Completion date	October 1, 2016

Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy — LCPVIH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms